跳至主要内容
临床试验/CTRI/2022/01/039683
CTRI/2022/01/039683尚未招募未知

Efficacy And Safety Of Lurasidone Versus Lamotrigine As An Adjunct Therapy In Bipolar-II Depression - Efficacy And Safety Of Lurasidone Versus Lamotrigine As An Adjunct Therapy In Bipolar-II Depression

Government medical college patiala0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Male and female patients aged 18-65 years with patient fulfilling DSM 5 criteria for bipolar II depression.
  • 2. Patients who will be medically stable .
  • 3. Patients who have given written informed consent

排除标准

  • 1. Patients with history of epilepsy, mental retardation or any other organic disorder.
  • 2. Pregnant women and lactating mothers.
  • 3.History of seizures, renal insufficiency or congestive heart failure.
  • 4.History of drug abuse and dependence in the last six months.
  • 5. Refusal to give informed consent
  • 6. History of hypesenstivity/rash/bronchial asthma.

研究者

相似试验